Calliditas Therapeutics ABCalliditas Therapeutics AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG rating for Calliditas Therapeutics AB indicates the company's reporting of the United Nations SDGs. The webpage is a free ESG assessment covering Calliditas Therapeutics AB. Full ESG assessment of Calliditas Therapeutics AB can be reached by signing up for free.

Calliditas Therapeutics AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 8.0, social score of 8.0 and governance score of 4.0.

SDG Transparency Score for Calliditas Therapeutics AB 
Low
0 - 3

6.9

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Calliditas Therapeutics AB 
8.0

Environmental

8.0

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
355Xbrane Biopharma AB
7.0
High
355Xenetic Biosciences Inc
7.0
High
387Calliditas Therapeutics AB
6.9
High
387Advanced Medical Solutions Group PLC
6.9
High
387Acrux Ltd
6.9
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Calliditas Therapeutics AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB report the average age of the workforce?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB offer flexible work?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB conduct supply chain audits?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Calliditas Therapeutics AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose water use targets?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Calliditas Therapeutics AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Calliditas Therapeutics AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Calliditas Therapeutics AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose its waste policy?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose energy use targets?

LockedSign up for free to unlock

Does Calliditas Therapeutics AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Calliditas Therapeutics AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Calliditas Therapeutics AB
These potential risks are based on the size, segment and geographies of the company.

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.

Sorry!

Failed to process!